CKPT — Checkpoint Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $103.54m
- $98.59m
- $0.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 26.1 | 40.8 | 54.7 | 12.1 | 4.93 |
Net Total Receivables | 0.026 | 0.02 | 0.017 | 0.073 | — |
Prepaid Expenses | |||||
Total Current Assets | 27 | 42.6 | 55.7 | 13.3 | 5.38 |
Total Assets | 27 | 42.6 | 55.7 | 13.3 | 5.38 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.12 | 7.22 | 26 | 32.8 | 18.4 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 8.12 | 7.22 | 26 | 32.8 | 18.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18.8 | 35.4 | 29.7 | -19.5 | -13 |
Total Liabilities & Shareholders' Equity | 27 | 42.6 | 55.7 | 13.3 | 5.38 |
Total Common Shares Outstanding |